Copay assistance programs are supposed to reduce drug costs and cover patients’ deductibles — so why are so many people getting stuck with a bill?
Health Care
Alzheimer’s Disease shrinks your brain — why do the new drugs for the condition do the same thing?
Drugmakers say small brain bleeds and swelling caused by the new Alzheimer’s drugs are benign and self-resolving — but are they?
Regulators approved controversial therapies amid excess deaths, questionable efficacy, and conflicts of interest.
A groundbreaking study finds doctors affiliated with hospitals and private equity firms are charging billions more annually than independent general practitioners.
“Uber for nurses” is extracting profits and hurting health care, all to solve a problem that doesn’t exist.
The country’s largest insurers spent $120 billion on stock buybacks since 2010, with nearly half of that spent by UnitedHealth.
Since the Affordable Care Act’s passage, the top five health insurers’ annual profits have jumped 230 percent, with much of that going to UnitedHealthcare.
In the heart of the state that could decide the election, people are grappling with a crisis largely ignored by both Trump and Harris.
The University of California has raked in a previously undisclosed $1.6 billion from Xtandi sales, and now doesn’t want the government lowering exorbitant drug costs.